Bausch + Lomb, the global eye health company, has appointed three industry veterans to key management roles in its Surgical business. Brad Paddock has been hired as vice president, Sales; Anthony Sine is appointed vice president, Business Development…
Category: Business
pSivida Corp. Reports Results for the First Quarter Ended September 30, 2010
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida reports first quarter fiscal 2011 results
InSite Vision Reports Third Quarter 2010 Financial Results
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB:INSV) today reported operating and financial results for the quarter ended September 30, 2010. Total revenue for the third quarter of 2010 was $3.2 million with an operating income of …
InSite Vision Awarded Therapeutic Discovery Project Grant for ISV-502 and ISV-303 Clinical Development
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB: INSV), a company developing novel ophthalmic therapeutics, today announced that it will receive $489,000 under the U.S. Government’s Qualifying Therapeutic Discovery Project (“QTDP”) …
Freedom Meditech Fills Executive Team
Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced the appointment of Keith D. Ignotz as President & Chief Operating Officer and John F. Burd, Ph.D. as Chief Science Off…
pSivida Corp Awarded Two Therapeutic Discovery Project Grants Totaling $489,000
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida receives two Therapeutic Discovery Project Grants totaling $489,000 for drug delivery technologies
STAAR Surgical third quarter total net sales increases 6% to $13.2 million
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the third quarter ended October 1, 2010. Revenue for the period grew 6% to $13.2 million reflecting core produ…
Akorn Reports Third Quarter 2010 Results
LAKE FOREST, Ill.–(BUSINESS WIRE)–Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the third quarter ended September 30, 2010. Consolidated revenue for the third quarter of 2010 was $21.7 millio…
Allergan third quarter diluted loss per share increases to $2.21
Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of reco…
Novartis Wins Challenge Against J&J Over Its French Contact Lens Patent
Novartis AG won an appeals court bid in Paris to uphold the French portion of its European patent for extended-wear lenses, defeating claims by Johnson & Johnson to overturn the intellectual-property protection. The ruling by Frances Court of App…
pSivida Corp Announces First Quarter 2011 Financial Results Release Date and Conference Call Information
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida announces first quarter 2011 financial results release date and conference call information
Ziemer Group Announces Product Upgrades
Ziemer Group (Port, Switzerland) unveiled its Femto LDV Crystal Line and launched its Dual Scheimpflug Camera System at the AAO Annual Meeting.The Femto LDV Crystal Line, known as Z-LASIK Crystal Plus, has a pulse rate of more than 5 MHz. According t…
InSite Vision to Report Third Quarter Financial Results on November 4, 2010
ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision Incorporated (OTCBB: INSV) announced today that it will report financial results for the third quarter ended September 30, 2010 on Thursday, November 4, 2010. Company management will also host a conferenc…
Celtic Therapeutics And Resolvyx Pharmaceuticals Announce An Alliance In Ophthalmology
Celtic Therapeutics Holdings L.P. (Celtic Therapeutics), a successor firm to Celtic Pharma, and Resolvyx Pharmaceuticals, Inc. (Resolvyx) announced that they have entered into an option agreement relating to Resolvyx’s RX-10045, a late-stage program fo…
Synergetics USA Announces New Products and Record Sales Lead Generation at AAO
Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced record sales leads generated from the presentation of recently released ophthalm…
Tobii Technology AB: Tobii Announces Free Development Kit, Online Portal to Help Scientists
STOCKHOLM & WASHINGTON–(BUSINESS WIRE)–Leader in eye-tracking products and technology introduces Tobii Application Market to facilitate global sharing of software applications and ideas Tobii Technology, the global market leader in eye tracking, has …
Synergetics announces record sales leads generated from ophthalmic products
Synergetics USA, Inc. a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced record sales leads generated from the presentation of recently released ophthalmic …
Report on Global Ophthalmology Drug and Devices Market
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. Wit…
Novartis’ Vasella elected chairman at Alcon
Novartis’ chairman Daniel Vasella was elected board chairman of Alcon, increasing the Swiss drugmaker’s grip of the U.S. eyecare company as it tries to buy the stake it does not already own. Alcon’s Independent Director’s Committee (IDC), which has r…
Report on global ophthalmology drug and devices market
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With …